Michael Centola

Dr. Centola, Ph.D., is the co-founder, Chief Executive Officer, and Chief Scientific Officer at Haus Bioceuticals. He is an inflammatory disease expert. At the National Institutes of Health, he created scientific breakthroughs that dramatically improved outcomes of a once deadly inflammatory disease. At Haus, his understanding of inflammatory disease helped craft natural products using the same rigorous testing as pharmaceutical medicines. His pioneering work enabled the creation of treatments with unprecedented efficacy and safety.